TY  - JOUR

T1  - What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries

JO  - European Heart Journal

PY  - 2020/11/01

AU  - Ray KK

AU  - Bridges I

AU  - Bruckert E

AU  - Van Hout B

AU  - Sibartie M

AU  - Villa G

ED  - 

DO  - DOI: 10.1093/ehjci/ehaa946.3004

PB  - Oxford University Press (OUP)

VL  - 41

IS  - Supplement_2

Y2  - 2024/10/22

ER  -